Database: Mortality by Cause of Death (The Netherlands): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 5: Line 5:
'''Sponsor, manager or home institution''': [[dataOwner::Centraal Bureau voor de Statistiek]].
'''Sponsor, manager or home institution''': [[dataOwner::Centraal Bureau voor de Statistiek]].


'''Available type of information''': [[availableVariable::number of deaths in the country population]]; [[availableVariable::main underlying cause of death]] (extensive list of 'three digit codes'); [[availableVariable::age]]; [[availableVariable::sex]]; [[availableVariable::year]]; Deceased; Leading causes of death; [[availableVariable::region]].
'''Available type of information''': [[availableVariable::number of deaths in the country population]]; main underlying cause of death (extensive list of 'three digit codes'); [[availableVariable::age]]; [[availableVariable::sex]]; [[availableVariable::year]]; Deceased; [[availableVariable::leading causes of death]]; [[availableVariable::region]].


'''Source of information''': Declaration of the cause of death and Basic personal registration (BRP) are sent from regional hospitals to the statistical organization.
'''Source of information''': Declaration of the cause of death and Basic personal registration (BRP) are sent from regional hospitals to the statistical organization.


'''Data level''': Patient level.
'''Data level''': [[dataLevel::patient level]].


'''Available date level''': National and Regional level.
'''Available date level''': [[availableDataLevel::national level]] and [[availableDataLevel::regional level]].


'''Number of Records:''' Unknown.
'''Number of Records:''' [[numberRecords::unknown]].


'''Date range''': 1996 onwards (national and regional level) and 1995 onwards (patient level).
'''Date range''': 1996 onwards (national and regional level) and [[dataStart::1995]] [[dataEnd::onwards]] (patient level).


'''Cancer Areas of Interest:''' Total neoplasms (C00-D48); Total malignant neoplasms (C00-C97);  Malignant neoplasms of lip, oral cavity and pharynx (C00-C14); Malignant neoplasms of oesophagus (C15); Malignant neoplasms of stomach (C16); Malignant neoplasms of colon (C18); Malignant neoplasms of rectum, rectosigmoid and anus (C19-C21); Malignants neoplasms of liver and intrahepatic bile ducts (C22.0 - C22.8); Malignant neoplasms of galbladder and bile ducts (C23-C24); Malignant neoplasms of pancreas (C25); Malignant neoplasms of larynx (C32); Malignant neoplasms of trachea, bronchus and lung, Trachea (windpipe) including branchings (C33-C34); Melanoma skin (C43); Malignant neoplasms of breast (C50); Malignant neoplasms of cervix uteri (C53); Malignant neoplasms of corpus uteri and uterus unspecified (C54-C55); Malignant neoplasms of ovary (C56); Malignant neoplasms of prostate (C61); Malignant neoplasms of kidney, except renal pelvis (C64); Malignant neoplasms of bladder (C67); Malignant neoplasms of lymphoid, heamatopoietic and related tissue (C81-C96); Other malignant neoplasms (C17, C22.9, C26-C31, C35-C41, C44-C49, C51-C52, C57-C60, C62-C63, C65-C66, C68-C80, C97); Other neoplasms (D00-D48) [https://www.cbs.nl/en-gb/figures/detail/7052eng].
'''Cancer Areas of Interest:''' Total neoplasms (C00-D48); Total malignant neoplasms (C00-C97);  Malignant neoplasms of lip, oral cavity and pharynx (C00-C14); Malignant neoplasms of oesophagus (C15); Malignant neoplasms of stomach (C16); Malignant neoplasms of colon (C18); Malignant neoplasms of rectum, rectosigmoid and anus (C19-C21); Malignants neoplasms of liver and intrahepatic bile ducts (C22.0 - C22.8); Malignant neoplasms of galbladder and bile ducts (C23-C24); Malignant neoplasms of pancreas (C25); Malignant neoplasms of larynx (C32); Malignant neoplasms of trachea, bronchus and lung, Trachea (windpipe) including branchings (C33-C34); Melanoma skin (C43); Malignant neoplasms of breast (C50); Malignant neoplasms of cervix uteri (C53); Malignant neoplasms of corpus uteri and uterus unspecified (C54-C55); Malignant neoplasms of ovary (C56); Malignant neoplasms of prostate (C61); Malignant neoplasms of kidney, except renal pelvis (C64); Malignant neoplasms of bladder (C67); Malignant neoplasms of lymphoid, heamatopoietic and related tissue (C81-C96); Other malignant neoplasms (C17, C22.9, C26-C31, C35-C41, C44-C49, C51-C52, C57-C60, C62-C63, C65-C66, C68-C80, C97); Other neoplasms (D00-D48) [https://www.cbs.nl/en-gb/figures/detail/7052eng].

Revision as of 17:13, 15 November 2023

[1]

Primary purpose: Publish data concerning the number of deaths in the territory.

Sponsor, manager or home institution: Centraal Bureau voor de Statistiek.

Available type of information: number of deaths in the country population; main underlying cause of death (extensive list of 'three digit codes'); age; sex; year; Deceased; leading causes of death; region.

Source of information: Declaration of the cause of death and Basic personal registration (BRP) are sent from regional hospitals to the statistical organization.

Data level: patient level.

Available date level: national level and regional level.

Number of Records: unknown.

Date range: 1996 onwards (national and regional level) and 1995 onwards (patient level).

Cancer Areas of Interest: Total neoplasms (C00-D48); Total malignant neoplasms (C00-C97); Malignant neoplasms of lip, oral cavity and pharynx (C00-C14); Malignant neoplasms of oesophagus (C15); Malignant neoplasms of stomach (C16); Malignant neoplasms of colon (C18); Malignant neoplasms of rectum, rectosigmoid and anus (C19-C21); Malignants neoplasms of liver and intrahepatic bile ducts (C22.0 - C22.8); Malignant neoplasms of galbladder and bile ducts (C23-C24); Malignant neoplasms of pancreas (C25); Malignant neoplasms of larynx (C32); Malignant neoplasms of trachea, bronchus and lung, Trachea (windpipe) including branchings (C33-C34); Melanoma skin (C43); Malignant neoplasms of breast (C50); Malignant neoplasms of cervix uteri (C53); Malignant neoplasms of corpus uteri and uterus unspecified (C54-C55); Malignant neoplasms of ovary (C56); Malignant neoplasms of prostate (C61); Malignant neoplasms of kidney, except renal pelvis (C64); Malignant neoplasms of bladder (C67); Malignant neoplasms of lymphoid, heamatopoietic and related tissue (C81-C96); Other malignant neoplasms (C17, C22.9, C26-C31, C35-C41, C44-C49, C51-C52, C57-C60, C62-C63, C65-C66, C68-C80, C97); Other neoplasms (D00-D48) [2].

Data access: Partially publicly available. National level data access [3]. Regional level data access [4]. Instructions to request data for restricted content [5].

Contact information: Information [6].